Systemic inflammation and cancer-related frailty: shifting the paradigm toward precision survivorship medicine
ESMO Open
.
2024 Jan;9(1):102205.
doi: 10.1016/j.esmoop.2023.102205.
Epub 2024 Jan 9.
Authors
A Di Meglio
1
,
I Vaz-Luis
2
Affiliations
1
Cancer Survivorship Group, INSERM U981, Gustave Roussy, Villejuif. Electronic address: antonio.di-meglio@gustaveroussy.fr.
2
Cancer Survivorship Group, INSERM U981, Gustave Roussy, Villejuif; Interdisciplinary Department for the Organization of Patient Pathways (DIOPP), Gustave Roussy, Villejuif, France.
PMID:
38194879
PMCID:
PMC10820355
DOI:
10.1016/j.esmoop.2023.102205
No abstract available
Publication types
Editorial
MeSH terms
Frailty* / epidemiology
Humans
Inflammation
Neoplasms* / complications
Precision Medicine
Survivorship